期刊文献+

Glycogen and amyloid-beta: key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer's disease? 被引量:3

Glycogen and amyloid-beta: key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer's disease?
下载PDF
导出
摘要 Introduction:Alzheimer’s disease(AD)begins to develop decades prior to its clinical manifestation(Sperling et al.,2011),and while it is the most common form of dementia,as of yet there is no cure.Two of the most researched pathological features contributing to disease development are the extracellular amyloid plaques composed of amyloid-beta proteins(Aβ)and neurofibrillary tangles of tau proteins.Another feature of AD is the progression of early neuronal excitability/hyperactivity to silencing/hypoactivity(Palop and Mucke,2010), Introduction:Alzheimer’s disease(AD)begins to develop decades prior to its clinical manifestation(Sperling et al.,2011),and while it is the most common form of dementia,as of yet there is no cure.Two of the most researched pathological features contributing to disease development are the extracellular amyloid plaques composed of amyloid-beta proteins(Aβ)and neurofibrillary tangles of tau proteins.Another feature of AD is the progression of early neuronal excitability/hyperactivity to silencing/hypoactivity(Palop and Mucke,2010),
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2015年第7期1023-1025,共3页 中国神经再生研究(英文版)
  • 相关文献

参考文献26

  • 1Barnes DE, Yaffe K (2011) The projected effect of risk factor reduc- tion on Alzheimer's disease prevalence. Lancet Neurol 10:819-828.
  • 2Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtz- man DM (2006) Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat Med 12:856- 861.
  • 3Beach TG, Wilson JR, Sue LI, Newell A, Poston M, Cisneros R, Pandya Y, Esh C, Connor DJ, Sabbagh M, Walker DG, Roher AE (2007) Circle of Willis atherosclerosis: association with Alzhei- mer's disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathol 113:13-21.
  • 4Belanger M, Allaman I, Magistretti PJ (2011) Brain energy metab- olism: focus on astrocyte-neuron metabolic cooperation. Cell Metab 14:724-738.
  • 5Brown AM (2004) Brain glycogen re-awakened. J Neurochem 89: 537-552.
  • 6Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Schoepp DD, Paul SM, Mennerick S, Holtzman DM (2005) Syn- aptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48:913-922.
  • 7Coskuner O, Murray IV (2014) Adenosine triphosphate (ATP) reduces amyloid-β protein misfolding in vitro. I Alzheimers Dis 41:561-574.
  • 8de la Monte SM (2012) Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res 9:35-66.
  • 9Elman JA, Oh H, Madison CM, Baker SL, Vogel JW, Marks SM, Crowley S, O'Neil JP, Jagust WJ (2014) Neural compensation in older people with brain amyloid-β deposition. Nat Neurosci 17:1316-1318.
  • 10Fogel H, Frere S, Segev O, Bharill S, Shapira I, Gazit N, O'Malley T, Slomowitz E, Berdichevsky Y, Walsh DM, Isacoff EY, Hirsch JA, Slutsky I (2014) APP homodimers transduce an amyloid-β-me- diated increase in release probability at excitatory synapses. Cell Rep 7:1560-1576.

同被引文献9

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部